Myriad Genetics reported $0 in Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Accelerate Diagnostics AXDX:US 107.3M 8.78M
Becton, Dickinson and BDX:US $ 16365M 2270M
Bio Rad Laboratories BIO:US $ 1197.41M 0.17M
Biocept BIOC:US $ 2.24M 0.27M
Bruker BRKR:US $ 1185M 31.4M
Danaher DHR:US $ 20062M 1716M
Exact Sciences EXAS:US $ 2242.84M 43.16M
Fluidigm FLDM:US $ 64.55M 35.49M
Hologic HOLX:US $ 2844.5M 248.6M
Illumina ILMN:US $ 1740M 0M
Mettler Toledo International MTD:US 1.93B 55.94M
Nanostring Technologies NSTG:US $ 225.88M 0.37M
Orasure Technologies OSUR:US $ 2.63M 0.28M
Pacific Biosciences Of California PACB:US $ 896.37M 0.15M
Perkinelmer PKI:US $ 4488.49M 379.21M
Quest Diagnostics DGX:US $ 3985M 2M
Repligen RGEN:US $ 283.71M 0.44M
Thermo Fisher Scientific TMO:US $ 30260M 2995M
Veracyte VCYT:US $ 1.73M 0.05M
Waters WAT:US $ 1484.37M 40.25M